Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Director | February 21, 2024 | February 24, 2024 |
| InnovAge Holding Corp.INNV · Entity 4693 | Director | July 01, 2026 | July 02, 2026 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date February 21, 2024 · Filed February 24, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 249,737 |
Reported balance
After 2024-02-21 transaction · row 1
1 source rowRow 1 · 2024-02-21 · Grant · Acquired 53,942 · Balance 249,737 F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.
InnovAge Holding Corp.
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 102,349 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 8,539 · Balance 102,349 F1: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by trust | 9,693 |
Reported balance
After 2026-10-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 9,693 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. F4: All shares held by the Richard Charles Zoretic Revocable Living Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
F4: All shares held by the Richard Charles Zoretic Revocable Living Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:54 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 304 | $180.85 | $54,978.40 |
DisclosureSEC source: 0001263714-26-000011 · wk-form4_1790974468.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 9,693 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 237 | $232.55 | $55,114.35 |
DisclosureSEC source: 0001263714-26-000009 · wk-form4_1783025633.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 9,389 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:33 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 8,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-26-000037 · wk-form4_1783024435.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,349 F1 · shares: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:46 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.82 | $55,007.10 |
DisclosureSEC source: 0001263714-26-000006 · wk-form4_1775162757.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 9,152 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 01:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | PurchaseCommon Stock | 800 | $125.16 | $100,128.00 |
DisclosureSEC source: 0001263714-26-000004 · wk-form4_1770946064.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 8,747 F1 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2026 Filed Jan 2, 2026 21:52 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 317 | $173.54 | $55,012.18 |
DisclosureSEC source: 0001263714-26-000002 · wk-form4_1767390758.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 7,947 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:08 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 285 | $192.79 | $54,945.15 |
DisclosureSEC source: 0001263714-25-000006 · wk-form4_1759450131.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 7,630 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:22 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 180 | $306.29 | $55,132.20 |
DisclosureSEC source: 0001179929-25-000112 · wk-form4_1751491331.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 7,345 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:20 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 25,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-25-000044 · wk-form4_1751487593.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,810 F1 · shares: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 30, 2025 Filed May 30, 2025 21:08 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 8,450 | $4.08 | $34,476.00 |
DisclosureSEC source: 0001834376-25-000021 · wk-form4_1748639277.xml · nonDerivative · entry 3 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,494 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.95 to $4.20, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:08 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 14,265 | $4.04 | $57,630.60 |
DisclosureSEC source: 0001834376-25-000021 · wk-form4_1748639277.xml · nonDerivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,044 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:08 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 20,000 | $4.06 | $81,200.00 |
DisclosureSEC source: 0001834376-25-000021 · wk-form4_1748639277.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,779 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.21, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 23, 2025 Filed May 23, 2025 20:31 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 1,198 | $3.93 | $4,708.14 |
DisclosureSEC source: 0001834376-25-000019 · wk-form4_1748032294.xml · nonDerivative · entry 3 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,779 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.94, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:31 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 700 | $4.09 | $2,863.00 |
DisclosureSEC source: 0001834376-25-000019 · wk-form4_1748032294.xml · nonDerivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,581 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.04 to $4.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:31 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 1,147 | $4.13 | $4,737.11 |
DisclosureSEC source: 0001834376-25-000019 · wk-form4_1748032294.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.07 to $4.17, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 20, 2025 Filed May 21, 2025 00:57 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 807 | $4.20 | $3,389.40 |
DisclosureSEC source: 0001834376-25-000017 · wk-form4_1747789014.xml · nonDerivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,734 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.13 to $4.23, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| May 16, 2025 Filed May 21, 2025 00:57 UTC | InnovAge Holding Corp. INNV · Entity 4693 | PurchaseCommon Stock, $0.001 par value | 2,086 | $4.28 | $8,928.08 |
DisclosureSEC source: 0001834376-25-000017 · wk-form4_1747789014.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,927 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.38, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.71 | $55,055.28 |
DisclosureSEC source: 0001179929-25-000064 · wk-form4_1743627704.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 7,165 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 22:18 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 189 | $291.05 | $55,008.45 |
DisclosureSEC source: 0001179929-25-000013 · wk-form4_1735856311.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,997 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:41 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 161 | $341.91 | $55,047.51 |
DisclosureSEC source: 0001179929-24-000138 · wk-form4_1727901705.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,808 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| September 05, 2024 Filed Sep 5, 2024 21:11 UTC | InnovAge Holding Corp. INNV · Entity 4693 | GrantCommon Stock, $0.001 par value | 19,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001834376-24-000068 · wk-form4_1725570654.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,841 F1 · shares: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on July 1, 2025, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000116 · wk-form4_1719953991.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,647 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000082 · wk-form4_1712091626.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,459 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:39 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 53,942 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-019652 · ownership.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,737 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| February 14, 2024 Filed Feb 21, 2024 02:50 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 103,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017538 · ownership.xml · derivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 10,317 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On February 14, 2023, the reporting person was granted 103,175 RSUs, which vested on February 14, 2024. F2 · derivative.expiration_date: On February 14, 2023, the reporting person was granted 103,175 RSUs, which vested on February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 21, 2024 02:50 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 103,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-017538 · ownership.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 00:25 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 152 | $361.31 | $54,919.12 |
DisclosureSEC source: 0001179929-24-000024 · wk-form4_1704241512.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,323 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 23:32 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.89 | $55,085.52 |
DisclosureSEC source: 0001179929-23-000126 · wk-form4_1696289555.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,171 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| August 15, 2023 Filed Aug 24, 2023 22:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 61,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-044441 · ownership.xml · derivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 61,611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On August 15, 2022, the reporting person was granted 61,611 restricted stock units, which vested on August 15, 2023. F2 · derivative.expiration_date: On August 15, 2022, the reporting person was granted 61,611 restricted stock units, which vested on August 15, 2023. Read SEC document |
| August 15, 2023 Filed Aug 24, 2023 22:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 61,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-044441 · ownership.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 183 | $301.24 | $55,126.92 |
DisclosureSEC source: 0001179929-23-000083 · wk-form4_1688417610.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,003 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000058 · wf-form4_168056216059264.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 5,820 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| February 14, 2023 Filed Feb 17, 2023 01:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 103,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005308 · doc4.xml · derivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,175 Underlying: Common Stock, par value $0.01 per share · 103,175 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:21 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000012 · wf-form4_167278808368311.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,614 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 17:46 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $329.84 | $55,083.28 |
DisclosureSEC source: 0001179929-22-000160 · wf-form4_166499199091415.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,447 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2022, of $329.84. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 22:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 61,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-029049 · doc4.xml · derivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,611 Underlying: Common Stock, par value $0.01 per share · 61,611 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 194 | $282.90 | $54,882.60 |
DisclosureSEC source: 0001179929-22-000103 · wf-form4_165671877809281.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,280 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2022, the first day of the quarter, was $282.90, which resulted in a grant of 194 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 01:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 10,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025156 · doc4.xml · derivative · entry 2 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 10,509 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022. F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 01:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 10,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-025156 · doc4.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:35 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000069 · wf-form4_164911890449409.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 5,086 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000014 · wf-form4_164125624097235.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,924 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 01:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 203 | $271.51 | $55,116.53 |
DisclosureSEC source: 0001179929-21-000158 · wf-form4_163339568078286.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,751 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2021, the first day of the quarter, was $271.51, which resulted in a grant of 203 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2021. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:07 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 215 | $256.05 | $55,050.75 |
DisclosureSEC source: 0001179929-21-000121 · wf-form4_162526004694812.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,548 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2021, the first day of the quarter, was $256.05, which resulted in a grant of 215 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2021. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 20:38 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 10,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027530 · doc4.xml · derivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,509 Underlying: Common Stock, par value $0.01 per share · 10,509 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: The RSUs vest on June 30, 2022. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on June 30, 2022. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:50 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 234 | $235.48 | $55,102.32 |
DisclosureSEC source: 0001179929-21-000077 · wf-form4_161766291834088.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,333 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2021, the first day of the quarter, was $235.48, which resulted in a grant of 234 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2021. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 00:44 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 259 | $212.68 | $55,084.12 |
DisclosureSEC source: 0001179929-21-000011 · wf-form4_160980747928646.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 4,099 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2021 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2020, of $212.68. Thus, the grant this quarter for services as a Director is for 259 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2020. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:10 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 292 | $188.18 | $54,948.56 |
DisclosureSEC source: 0001179929-20-000127 · wf-form4_160167659857504.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 3,840 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2020 was $188.18, which resulted in a grant of 292 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2020. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:25 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 307 | $179.12 | $54,989.84 |
DisclosureSEC source: 0001179929-20-000100 · wf-form4_159373230669053.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 3,548 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2020 was $179.12, which resulted in a grant of 307 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2020. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2020 Filed Apr 4, 2020 00:28 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 419 | $131.16 | $54,956.04 |
DisclosureSEC source: 0001179929-20-000063 · wf-form4_158596011244284.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 3,241 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2020, the first day of the quarter, was $131.16, which resulted in a grant of 419 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2020. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:58 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.69 | $54,954.45 |
DisclosureSEC source: 0001179929-20-000015 · wf-form4_157809591368304.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by trust Disclosed balance after: 2,822 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2020 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2019, of $135.69. Thus, the grant this quarter for services as a Director is for 405 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2019. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.